Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion type Assertion NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_head.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion description "[Considering that inclusions of lipofuscin-like substances are observed in retinal pigmentary cells of patients with Stargardt's disease on the one hand, and that the early symptoms of neuronal ceroid lipofuscinosis (CLN3) are suggestive of Stargardt's disease on the other hand (age of loss of visual acuity, appearance of the fundus), we decided to test allelism of Stargardt's disease with the infantile (CLN1) and juvenile forms of neuronal ceroid lipofuscinosis (CLN3), which map to chromosomes 1p32 and 16p12-p11 respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_provenance.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion evidence source_evidence_literature NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_provenance.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion SIO_000772 8014971 NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_provenance.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion wasDerivedFrom befree-20140225 NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_provenance.
- NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_assertion wasGeneratedBy ECO_0000203 NP245438.RA-5TBAU5pr0la_UIsHmyl8fJRYs7q7_bV3VUI_KH03oE130_provenance.